Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Fierce Pharma
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
CVS will restore coverage to obesity products from Eli Lilly, allowing patients to gain access to the drugs through their existing insurance.
Kevin Dunleavy
May 28, 2026 11:20am
Him & Hers now offers all FDA-approved GLP-1s
Apr 23, 2026 10:43am
Fierce Pharma
Lilly lowers self-pay prices of single-dose Zepbound vials
Dec 1, 2025 8:00am
Fierce Pharma
Lilly, Novo reach GLP-1 pricing deals with White House
Nov 6, 2025 12:26pm
Fierce Pharma
Novo, Lilly obesity meds 'highly cost-effective': ICER report
Sep 9, 2025 10:30am
CVS hit with lawsuit over dropping Zepbound from formulary
Sep 5, 2025 4:58pm